Autolus Therapeutics plc
AUTLNasdaqCIK 1730463HealthcareFiscal year ends Dec 31
Reports and events: 133 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2821:08 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-26-095283 |
| 2026-08-1116:13 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001730463-26-000123 |
| 2026-08-1107:33 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000119 |
| 2026-08-0308:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-26-000112 |
| 2026-08-0307:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-329526 |
| 2026-06-2916:03 ET | 8-K | 5.07 Shareholder vote results | 0001730463-26-000072 |
| 2026-06-0907:30 ET | 8-K | 8.01 Other events | 0001730463-26-000069 |
| 2026-05-1416:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001730463-26-000065 |
| 2026-05-1407:53 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000058 |
| 2026-04-2917:28 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-192362 |
| 2026-04-1616:08 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001730463-26-000049 |
| 2026-04-0816:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000043 |
| 2026-03-2716:39 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001730463-26-000038 |
| 2026-03-2708:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-26-000032 |
| 2026-01-2616:07 ET | 8-K | 1.01 Entry into a material agreement | 0001730463-26-000019 |
| 2026-01-1208:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-26-000012 |
| 2025-12-0216:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001730463-25-000095 |
| 2025-11-1216:22 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001730463-25-000088 |
| 2025-11-1208:13 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000081 |
| 2025-08-1216:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001730463-25-000067 |
| 2025-08-1208:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000064 |
| 2025-06-2708:47 ET | 8-K | 5.07 Shareholder vote results | 0001730463-25-000046 |
| 2025-06-0216:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-25-000043 |
| 2025-05-3016:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-132111 |
| 2025-05-0817:08 ET | S-1 | Registration statement | 0001193125-25-116059 |
| 2025-05-0816:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001730463-25-000039 |
| 2025-05-0808:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000032 |
| 2025-04-2306:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000022 |
| 2025-04-0316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-072356 |
| 2025-03-2016:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001730463-25-000019 |
| 2025-03-2007:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000010 |
| 2025-01-1306:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-25-000004 |
| 2024-11-1216:27 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001730463-24-000136 |
| 2024-11-1207:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000132 |
| 2024-11-1206:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-24-000129 |
| 2024-10-2516:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-090768 |
| 2024-09-2607:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000110 |
| 2024-09-1908:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001730463-24-000104 |
| 2024-09-1309:08 ET | 8-K | 1.01 Entry into a material agreement | 0001730463-24-000099 |
| 2024-08-0816:21 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001730463-24-000093 |
| 2024-08-0808:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000088 |
| 2024-06-2816:04 ET | 8-K | 5.07 Shareholder vote results | 0001730463-24-000076 |
| 2024-06-0516:35 ET | 8-K | 8.01 Other events | 0001730463-24-000074 |
| 2024-06-0317:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000070 |
| 2024-05-1716:39 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001730463-24-000064 |
| 2024-05-1708:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000059 |
| 2024-05-1307:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-136696 |
| 2024-04-0107:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001730463-24-000050 |
| 2024-03-2516:10 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-025536 |
| 2024-03-2116:55 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001730463-24-000048 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.